Ix Biopharma Ltd. announced the appointment of Iain Bruce Cook as Chief Scientist, effective September 25, 2015. He is responsible for the obtaining, assessing, implementing and propagating all relevant strategic scientific knowledge.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.039 SGD | -2.50% | 0.00% | -13.33% |
12/03 | Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer | MT |
12/03 | IX Biopharma Introduces New Sublingual Wafer | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.33% | 2.22Cr | |
+38.51% | 73TCr | |
+31.74% | 60TCr | |
-6.23% | 35TCr | |
+18.78% | 33TCr | |
+1.35% | 28TCr | |
+16.00% | 24TCr | |
+8.44% | 20TCr | |
-5.97% | 20TCr | |
+6.19% | 16TCr |
- Stock Market
- Equities
- 42C Stock
- News iX Biopharma Ltd.
- Ix Biopharma Ltd. Announces Appointment of Iain Bruce Cook as Chief Scientist